Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

38.52
Delayed Data
As of Apr 29
 -0.68 / -1.73%
Today’s Change
27.68
Today|||52-Week Range
40.96
-3.72%
Year-to-Date
Seattle Genetics (SGEN) Posts Wider-than-Expected Q1 Loss
Apr 29 / Zacks.com
The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL ...
Apr 27 / Zacks.com
BioMarin (BMRN) Reports Narrower-than-Expected Q1 Loss
Apr 29 / Zacks.com
Perrigo's CEO Resigns, Trims 2016 Outlook, Stock Tumbles
Apr 26 / Zacks.com
United (UTHR) Stock Declines Despite Q1 Earnings Beat
Apr 29 / Zacks.com
5 Stocks to Invest on Healthcare Rebound
Apr 26 / Zacks.com
Agenus' (AGEN) Q1 Loss Wider than Expected, Revenue Miss
Apr 29 / Zacks.com
UCB (UCBJF) Posts Q1 Results, Reiterates 2016 Guidance
Apr 26 / Zacks.com
Acorda (ACOR) Q1 Earnings Decline Y/Y, Ampyra in Focus
Apr 29 / Zacks.com
Top 5 Stocks with Increasing Cash Flows
Apr 25 / Zacks.com
5 Sturdy Stocks to Play Weakest Growth in 2 Years
Apr 29 / Zacks.com
New Lifetime High For Emergent BioSolutions (EBS)
Apr 25 / TheStreet.com
Alkermes (ALKS) Reports Narrower-than-Expected Q1 Loss
Apr 29 / Zacks.com
Biogen (BIIB) Tops on Q1 Earnings, Slight Revenue Miss
Apr 21 / Zacks.com
Gilead (GILD) Lags Q1 Earnings & Revenues, '16 View Intact
Apr 29 / Zacks.com
Amgen's (AMGN) Phase III Study Results on Nplate Published
Apr 20 / Zacks.com
Alexion (ALXN) Lags Q1 Earnings & Revenues, Revises View
Apr 28 / Zacks.com
Pfizer Reports Positive Data on Breast Cancer Drug Ibrance
Apr 20 / Zacks.com
GlaxoSmithKline (GSK) Q1 Earnings Lag, Revenues Up Y/Y
Apr 28 / Zacks.com
ARIAD Gains on Updated Brigatinib Phase I/II Study Data
Apr 19 / Zacks.com
Bristol-Myers (BMY) Tops Q1 Earnings, Updates 2016 View
Apr 28 / Zacks.com
Gilead Presents Multiple HCV and HBV Data at Liver Congress
Apr 19 / Zacks.com
Celgene (CELG) Beats on Q1 Earnings, Updates '16 Outlook
Apr 28 / Zacks.com